ErikssonPO, HellstromS.Degranulation of mast cells provokes a massive inflammatory reaction in the tympanic membrane. Laryngoscope2001; 111:1264–70.
2.
van der VenLT, van den DobbelsteenGP, NagarajahB. A new rat model of otitis media caused by Streptococcus pneumoniae: conditions and application in immunization protocols. Infect Immun1999;67:6098–103.
3.
LabadieRF, JewettBS, HartCF, PrazmaJ, PillsburyHCIII. Allergy increases susceptibility to otitis media with effusion in a rat model. Otolaryngol Head Neck Surg1999:121: 687–92.
4.
JewettBS, PrazmaJP, HunterSE. Systemic reactivation of otitis media with effusion in a rat model. Otolaryngol Head Neck Surg1999;121:7–12.
5.
HultcrantzM, ErichsenS, RylanderR.StiernaP, Bag-ger-SjobackD.Labeling of the glucocorticoid receptor and Na, K-ATPase in a rat otitis media model. Am J Otol2000;21:36–41.
6.
NellMJ, GroteJJ. Efficacy of bactericidal/permeability-increasing protein in experimental otitis media with effusion in rats: a new therapy for mucosal infections. J Lab Clin Med2001;137:303–9.
7.
JeonE, ParkY-S, ChoiY-C, YeoSW, JungTTK. Effect of inhibitor of tumor necrosis factor-alpha on experimental otitis media with effusion. Ann Otol Rhinol Laryngol2001; 110:917–21.
8.
TadaN, FurukawaM, OguraM. Experimental otitis media with effusion induced by leukotriene D4. Auris Nasus Larynx2002;29:127–32.
9.
KawanoH, HarutaA, TsuboiY. Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: the pathological basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol2002; 111:415–22.
10.
LinJ, HarutaA, KawanoH. Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-alpha: potential cause for mucoid otitis media. J Infect Dis2000; 182:882–7.
11.
TsuboiY, KimY, PaparellaMM, ChenN, SchachemPA, LinJ.Pattern changes of mucin gene expression with pneumococcal otitis media. Int J Pediatr Otorhinolaryngol2001; 61: 23–30.
12.
ChenYP, TongHH, JamesM.DemariaTF. Detection of mucin gene expression in normal rat middle ear mucosa by reverse transcriptase-polymerase chain reaction. Acta Otolaryngol (Stockh)2001;121:45–51.
13.
KimYT, JungHH, KoTO, KimSJ. Up-regulation of MUC5AC mRNA expression in endotoxin-induced otitis media. Acta Otolaryngol (Stockh)2001;121:364–70.
14.
Caye-ThomasenP.HermanssonA.TosM.PrellnerK.Middle ear secretory capacity after acute otitis media caused by Streptococcus pneumoniae. Moraxella catarrhalis, non-type-able or type B Haemophilus influenzae. A comparative analysis based on goblet cell density. Acta Otolaryngol Suppl (Stockh)2000(suppl 543):54–5.
15.
Caye-ThomasenP.TosM.Adaptive bone modeling and remodeling in acute otitis media caused by non-typeable or type B Haemophilus influenzae or Moraxella catarrhalis.Acta Otolaryngol (Stockh)2000;120:815–20.
16.
Caye-ThomasenP.TosM.Polyp and fibrous adhesion formation in acute otitis media caused by non-typeable or type b Haemophilus influenzae or Moraxella catarrhalis. Acta Otolaryngol (Stockh)2000;120:810–4.
17.
Forseni FlodinM.Macrophages and possible osteoclast differentiation in the rat bullar bone during experimental acute otitis media, with reference to tympanosclerosis. Otol Neurotol2001;22:771–5.
18.
WielingaEW, PetersTA, TonnaerEL, KuijpersW.CurfsJH. Middle ear effusions and structure of the tympanic membrane. Laryngoscope2001; 111:90–5.
19.
RussellJD, GilesJJ. Tympanosclerosis in the rat tympanic membrane: an experimental study. Laryngoscope2002; 112:1663–6.
20.
MelhusA.RyanAF. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect Immun2000;68:4024–31.
21.
MelhusA.RyanAF. Expression of molecular markers for bone formation increases during experimental acute otitis media. Microb Pathog2001;30:111–20.
22.
HebdaPA, PiltcherOB, SwartsJD. AlperCM, ZeeviA.DoyleWJ. Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection. Laryngoscope2002: 112:1657–62.
23.
ForseniM.MelhusA.RyanAF, Bagger-SjobackD.HultcrantzM.Detection and localization of interleukin-6 in the rat middle ear during experimental acute otitis media, using mRNA in situ hybridization and immunohistochemistry. Int J Pediatr Otorhinolaryngol2001; 57:115–21.
24.
PalaciosSD, PakK.KayaliAG. Participation of Ras and extracellular regulated kinase in the hyperplastic response of middle-ear mucosa during bacterial otitis media. J Infect Dis2002;186:1761–9.
25.
LinJ.TsuboiY.PanW.GiebinkGS, AdamsGL, KimY.Analysis by cDNA microarrays of altered gene expression in middle ears of rats following pneumococcal infection. Int J Pediatr Otorhinolaryngol2002;65:203–11.
26.
NordangL.AnnikoM.Hearing loss in relation to round window membrane morphology in experimental chronic otitis media. ORL J Otorhinolaryngol Relat Spec2001; 63:333–40.
27.
YoonYJ, HellstromS.Ultrastructural characteristics of the round window membrane during pneumococcal otitis media in rat. J Korean Med Sci2002;17:230–5.
28.
Caye-ThomasenP.HermanssonA.TosM.PrellnerK.Effect of penicillin on experimental acute otitis media. A histo-pathological study of goblet cell density, bone modelling dynamics, polyp and adhesion formation. Acta Otolaryngol Suppl (Stockh)2000(suppl 543):56–7.
29.
MelhusA.Effects of amoxicillin on the expression of cytokines during experimental acute otitis media caused by non-typeable Haemophilus influenzae. J Antimicrob Chemother2001;48:397–402.
30.
WestmanE.MelhusA.The treatment of Haemophilus influenzae acute otitis media with amoxicillin protects against reinfection but not against structural changes. J Antimicrob Chemother2002;49:141–7.
31.
OzcanC.PolatG.GorurK.TalasDU, BagdatogluO.CinelI.The effect of local administration of N-acetylcysteine in perforated rat tympanic membrane: an experimental study in myringosclerosis. Pharmacol Res2002;45:5–9.
32.
HebdaPA, BurckarGJ, AlperCM. Effect of 10 pharmacologic probes on mRNA levels of inducible nitric oxide synthetase and selected inflammatory cytokines in a rat model of acute otitis media. Acta Otolaryngol (Stockh)2002; 122: 255–61.
33.
WhiteP.HermanssonA.SvanborgC.BrilesD.PrellnerK.Effects of active immunization with a pneumococcal surface protein (PspA) and of locally applied antibodies in experimental otitis media. ORL J Otorhinolaryngol Relat Spec1999; 61:206–11.
34.
HerbertMA, HayesS.DeadmanME, TangCM, HoodDW, MoxonER. Signature tagged mutagenesis of Haemophilus influenzae identifies genes required for in vivo survival. Microb Pathog2002:33:211–23.
35.
HardySM. HeavnerSB, WhiteDR, McQueenCT, Praz-maJ.PillsburyHC. Late-phase allergy and eustachian tube dysfunction. Otolaryngol Head Neck Surg2001;125:339–45.
36.
EbertCSJr. PollockHW, DubinMG. Effect of intranasal histamine challenge on eustachian tube function. Int J Pediatr Otorhinolaryngol2002;63:189–98.
37.
DubinMG, PollockHW, EbertCS, BergE.BuentingJE, PrazmaJP. Eustachian tube dysfunction after tobacco smoke exposure. Otolaryngol Head Neck Surg2002;126:14–9.
38.
WhiteDR. HeavnerSB, HardySM, PrazmaJ.Gastroesophageal reflux and eustachian tube dysfunction in an animal model. Laryngoscope2002;112:955–61.
39.
HeavnerSB, HardySM, WhiteDR, McQueenCT, PrazmaJ.PillsburyHCIII. Function of the eustachian tube after weekly exposure to pepsin/hydrochloric acid. Otolaryngol Head Neck Surg2001;125:123–9.
40.
TsuboiY.KimY.GiebinkGS. Induction of mucous cell metaplasia in the middle ear of rats using a three-step method: an improved model for otitis media with mucoid effusion. Acta Otolaryngol (Stockh)2002;122:153–60.
41.
PiltcherOB, SwartsJD, MagnusonK.AlperCM, DoyleWJ, HebdaPA. A rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection: methods and disease course. Otolaryngol Head Neck Surg2002;126:490–8.
42.
MooreR.LidburyBA, CrippsAW, KydJM. Viral co-infection does not reduce the efficacy of vaccination against non-typeable Haemophilus influenzae middle ear infection in a rat model. ORL J Otorhinolaryngol Relat Spec2001; 63:96–101.
43.
PostJC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope2001:111:2083–94.
44.
EhrlichGD, VeehR.WangX.. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA2002;287:1710–5.
45.
MasonKM, MunsonRSJr, BakaletzLO. Nontypeable Haemophilus influenzae gene expression induced in vivo in a chinchilla model of otitis media. Infect Immun2003;71:3454–62.
46.
NovotnyLA, PichicheroME, DenoelPA. Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media. Vaccine2002;20:3590–7.
47.
NovotnyLA, BakaletzLO. The fourth surface-exposed region of the outer membrane protein P5-homologous adhesin of nontypeable Haemophilus influenzae is an immunodominant but nonprotective decoying epitope. J Immunol2003;171:1978–83.
48.
TongHH, BlueLE, JamesMA, DeMariaTF. Evaluation of the virulence of a Streptococcus pneumoniae neuramini-dase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun2000;68:921–4.
49.
TongHH, BlueLE, JamesMA, ChenYP, DeMariaTF. Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun2000;68:4593–7.
50.
SpectorBC. ReinischL.SmithD.WerkhavenJA. Noninvasive fluorescent identification of bacteria causing acute otitis media in a chinchilla model. Laryngoscope2000; 110:1119–23.
51.
BakaletzLO, KennedyBJ, NovotnyLA, DuquesneG.CohenJ.LobetY.Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect Immun1999;67:2746–62. [Erratum in Infect Immun 1999:67:5545.]
52.
BakaletzLO. Peptide and recombinant antigens for protection against bacterial middle ear infection. Vaccine2001; 19: 2323–8.
53.
KennedyBJ, NovotnyLA, JurcisekJA, LobetY.BakaletzLO. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge. Infect Immun2000;68:2756–65.
54.
BolducGR, BouchetV.JiangRZ. Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun2000;68:4505–17.
55.
SunJ.ChenJ.ChengZ.RobbinsJB, BatteyJF, GuXX. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model. Vaccine2000;18:1264–72.
56.
HajekDM, QuarteyM.GiebinkGS. Maternal pneumococcal conjugate immunization protects infant chinchillas in the pneumococcal otitis media model. Acta Otolaryngol (Stockh)2002;122:262–9.
57.
HuangY.JiP.InanoA.YangZ.GiebinkGS, SawchukRJ. Microdialysis studies of the middle ear distribution kinetics of amoxicillin in the awake chinchilla. J Pharm Sci2001; 90: 2088–98.
58.
BablFE, PeltonSI. LiZ.Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. Antimicrob Agents Chemother2002;46:2194–9.
59.
PeltonSI, FigueiraM.AlbutR.StalkerD.Efficacy of linezolid in experimental otitis media. Antimicrob Agents Chemother2000;44:654–7.
60.
TongHH, FisherLM, KosunickGM. DeMariaTF. Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla. Ann Otol Rhinol Laryngol2000;109:1021–7.
61.
TongHH, WeiserJN, JamesMA, DeMariaTF. Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model. Infect Immun2001;69:602–6.
62.
FunkeB.EpsteinJA, KochilasLK. Mice overex-pressing genes from the 22q 11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects. Hum Mol Genet2001;10:2549–56.
63.
HultcrantzM.StenbergAE. FranssonA.CanlonB.Characterization of hearing in an X,0 “Turner mouse.”Hear Res2000;143:182–8.
64.
HardistyRE, ErvenA.LoganK.. The deaf mouse mutant Jeff (Jf) is a single gene model of otitis media. J Assoc Res Otolaryngol2003;4:130–8.
65.
PrinceJE, BraytonCF, FossettMC. The differential roles of LFA-1 and Mac-1 in host defense against systemic infection with Streptococcus pneumoniae. J Immunol2001; 166: 7362–9.
66.
KodamaS.SuenagaS.HiranoT.SuzukiM.MogiG.Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization. Infect Immun2000;68:2294–300.
67.
SabirovA.KodamaS.HiranoT.SuzukiM.MogiG.Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect Immun2001;69:2964–71.
68.
KuronoY.SuzukiM.MogiG.. Effects of intranasal immunization on protective immunity against otitis media. Int J Pediatr Otorhinolaryngol1999;49(suppl 1):S227–S229.
69.
HiranoT.HouY.JiaoX.GuXX. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx. FEMS Immunol Med Microbiol2003;35:1–10.
70.
JohnsonSE, DykesJK, JueDL, SampsonJS, CarloneGM, AdesEW. Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a. J Infect Dis2002;185:489–96.
71.
ZhangY.MasiAW, BarniakV.MountzourosK.Hostet-terMK, GreenBA. Recombinant PhpA protein, a unique histi-dine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infect Immun2001;69:3827–36.
72.
IchimiyaI.SuzukiM.HiranoT.MogiG.The influence of pneumococcal otitis media on the cochlear lateral wall. Hear Res1999;131:128–34.
73.
HiranoT.KuronoY.IchimiyaI.SuzukiM.MogiG.Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization. Otolaryngol Head Neck Surg1999;121:616–21.
74.
TakoudesTG, HaddadJJr.Lipid peroxides in middle ear fluid after acute otitis media in guinea pigs. Ann Otol Rhinol Laryngol1999;108:564–8.
75.
DonerF.DelibasN.DogruH.YariktasM.DemirciM.The role of free oxygen radicals in experimental otitis media. J Basic Clin Physiol Pharmacol2002;13:33–40.
76.
RyanAF, BennettT.Nitric oxide contributes to control of effusion in experimental otitis media. Laryngoscope2001; 111:301–5.
77.
SatoK.KawanaM.NonomuraN.NakanoYCourse of IL-lbeta, IL-6, IL-8, and TNF-alpha in the middle ear fluid of the guinea pig otitis media model induced by nonviable Haemophilus influenzae. Ann Otol Rhinol Laryngol1999; 108:559–63.
78.
SchousboeLP, RasmussenLM, OvesenT.Induction of mucin and adhesion molecules in middle ear mucosa. Acta Otolaryngol (Stockh)2001;121:596–601.
79.
CookRD, PostmaDS, BrinsonGM, PrazmaJ.PillsburyHC. Cytotoxic changes in hair cells secondary to pneumococcal middle-ear infection. J Otolaryngol1999;28:325–31.
80.
ParraA.PonteC.CenjorC. Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model. Antimicrob Agents Chemother2002;46:859–62.
81.
HoriR.ArakiH.YonezawaM.MinamiS.WatanabeYTherapeutic effects of parenteral beta-lactam antibiotics on experimental otitis media caused by penicillin-resistant Streptococcus pneumoniae in guinea-pigs. J Antimicrob Chemother2000;45:311–4.
82.
TakoudesTG, HaddadJJr.Free radical production by antibiotic-killed bacteria in the guinea pig middle ear. Laryngoscope2001; 111:283–9.
83.
KarasenRM, SutbeyazY.AktanB.OzdcmirH.Gundog-duC.Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the guinea pig model of middle ear inflammation. Ann Otol Rhinol Laryngol2000:109:549–53.
84.
SuzukiM.KerakawauchiH.KawauchiH.MogiG.Efficacy of an antiallergic drug on otitis media with effusion in association with allergic rhinitis. An experimental study. Ann Otol Rhinol Laryngol1999;108:554–8.
85.
GhadialiSN, BanksJ.SwartsJD. Effect of surface tension and surfactant administration on eustachian tube mechanics. J Appl Physiol2002;93:1007–14.
86.
KotenM.UzunC.YagizR.. Nebulized surfactant as a treatment choice for otitis media with effusion: an experimental study in the rabbit. J Laryngol Otol2001;115:363–8.
87.
JinS.MoonSK, GuXX, UeyamaS.RhimJS, LimDJ. Immortalization of rat eustachian tube epithelial cells by adenovirus 12-simian virus 40 hybrid virus. Ann Otol Rhinol Laryngol2002;111:919–25.
88.
ChunYM, MoonSK, LeeHY. Immortalization of normal adult human middle ear epithelial cells using a retrovirus containing the E6/E7 genes of human papillomavirus type 16. Ann Otol Rhinol Laryngol2002; 111:507–17.
89.
UeyamaS.JinS.RhimJS, UeyamaT.LimDJ. Immortalization of rat middle ear epithelial cells by adeno 12-SV40 hybrid virus. Ann Otol Rhinol Laryngol2001:110:132–41.
90.
JinS.GuXX, RhimJS, LimDJ. Immortalization of chinchilla middle ear epithelial cells by adenovirus 12-simian virus 40 hybrid virus. Ann Otol Rhinol Laryngol1999; 108:934–43.
91.
MoonSK, LeeHY, LiJD. Activation of a Src-dependent Raf-MEKl/2-ERK signaling pathway is required for IL-1 alpha-induced upregulation of beta-defensin 2 in human middle ear epithelial cells. Biochim Biophys Acta2002; 1590:41–51.
92.
ShutoT.XuH.WangB.. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by tolllike receptor 2-TAK1 -dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci USA2001;98:8774–9.
93.
ShutoT.ImasatoA.JonoH.. Glucocorticoids syn-ergistically enhance nontypeable Haemophilus influenzae-in-duced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem2002;277:17263–70.
94.
WangB.LimDJ, HanJ.KimYS, BasbaumCB, LiJD. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinosittde 3-kinase-Akt pathway. J Biol Chem2002:277:949–57.
95.
CraigJE, CliffeA.GarnettK.HighNJ. Survival of nontypeable Haemophilus influenzae in macrophages. FEMS Microbiol Lett2001;203:55–61.
96.
van SchilfgaardeM.van UlsenP.EijkP.. Characterization of adherence of nontypeable Haemophilus influenzae to human epithelial cells. Infect Immun2000;68:4658–65.
97.
PortierF.HsuWC. HermanP.TranBaHuyP.Serous or mucoid effusion in the course of secretory otitis media: influence of ion transport modulation. Auris Nasus Larynx2001;28: 3–7.
HimiT.KitaH.MitsuzawaH.. Effect of Alloiococ-cus olitidis and three pathogens of otitis media in production of interleukin-12 by human monocyte cell line. FEMS Immunol Med Microbiol2000;29:101–6.
100.
KitaH.HimiT.FujiiN.YlikoskiJ.Interleukin-8 secretion of human epithelial and monocytic cell lines induced by middle ear pathogens. Microbiol Immunol2000;44:511–7.
101.
RosserTL. AcostaMT, PackerRJ. Aicardi syndrome: spectrum of disease and long-term prognosis in 77 females. Pe-diatr Neurol2002;27:343–6.
102.
OrangeJS, RameshN.Remoid-O'DonnellE.. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizcs with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci USA2002;99:11351–6.
103.
StenbergAE. WangH.SahlinL.StiernaP.EnmarkE.HultcrantzM.Estrogen receptors alpha and beta in the inner ear of the “Turner mouse” and an estrogen receptor beta knockout mouse. Hear Res2002; 166:1–8.
104.
BarrenasM.Landin-WilhelmsenK.HansonC.Ear and hearing in relation to genotype and growth in Turner syndrome. Hear Res2000;144:21–8.
105.
KomfeldSJ. ZeffrenB.ChristodoulouCS, DayNK, CawkwellG.GoodRA. DiGeorge anomaly: a comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization. J Allergy Clin Immunol2000;105:983–7.
106.
DanielE.McCurdyEA. ShashiV.McGuirtWFJr. Ectodermal dysplasia: otolaryngologic manifestations and management. Laryngoscope2002;112:962–7.
107.
Joki-ErkkilaVP, PuhakkaH.HurmeM.Cytokine gene polymorphism in recurrent acute otitis media. Arch Otolaryngol Head Neck Surg2002;128:17–20.
108.
RametM.LofgrenJ.AlhoOP, HallmanM.Surfactant protein-A gene locus associated with recurrent otitis media. J Pediatr2001;138:266–8.
109.
CasselbrantML, MandelEM, FallPA. The herita-bility of otitis media: a twin and triplet study. JAMA1999;282:2125–30.
110.
CasselbrantML, MandelEM. The genetics of otitis media. Curr Allergy Asthma Rep2001;1:353–7.
111.
RoversM.HaggardM.GannonM.Koeppen-SchomerusG.PlominR.Heritability of symptom domains in otitis media: a longitudinal study of 1,373 twin pairs. Am J Epidemiol2002; 155:958–64.
112.
ClarkJM. BrinsonG.NewmanMK. An animal model for the study of genetic predisposition in the pathogenesis of middle ear inflammation. Laryngoscope2000; 110:1511–5.
113.
PalvaT, RamsayH.Fate of the mesenchyme in the process of pneumatization. Otol Neurotol2002;23:192–9.
114.
JaisinghaniVJ, PaparellaMM, SchachernPA, SchneiderDS, LeCT. Residual mesenchyme persisting into adulthood. Am J Otolaryngol1999;20:363–70.
115.
RamsayH.PalvaT.NorthropC.Spread and fate of amniotic fluid cellular content in the middle ear. Acta Otolaryngol (Stockh)2001;121:190–3.
116.
PalvaT.NorthropC.RamsayH.Foreign body neonatal otitis media in infants. Otol Neurotol2001;22:433–43.
117.
PalvaT.NorthropC.RamsayH.Effect of amniotic fluid cellular content on attic aeration pathways: histologic observations of infants aged 2 to 4 months. Am J Otol2000;21:62–70.
118.
PalvaT.NorthropC.RamsayH.Spread of amniotic fluid cellular content within the neonate middle ear. Int J Pediatr Otorhinolaryngol1999;48:143–53.
119.
TekinM.SchachernPA, MutluC.JaisinghaniVJ, PaparellaMM, LeCT. Purulent otitis media in children and adults. Eur Arch Otorhinolaryngol2002;259:67–72.
120.
TekinM.MutluC.PaparellaMM, SchachernPA, JaisinghaniVJ, LeCT. Tympanic membrane and middle ear pathologic correlates in mucoid otitis media. Otolaryngol Head Neck Surg2000;123:258–62.
121.
LinJ.TsuprunV.KawanoH.. Characterization of mucins in human middle ear and eustachian tube. Am J Physiol Lung Cell Mol Physiol2001;280:L1157–L1167.
YildirimN.SoneM.MutluC.SchachernPA, PaparellaMM, LeCT. Histopathologic features of the temporal bone in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg2000;126:75–8.
124.
KamimuraM.SandoI.BalabanCD, HaginomoriS.Mu-cosa-associated lymphoid tissue in middle ear and eustachian tube. Ann Otol Rhinol Laryngol2001;110:243–7.
125.
MiuraM.SandoI, OritaY.HirschBE. Histopathologic study of the temporal bones and eustachian tubes of children with cholesterol granuloma. Ann Otol Rhinol Laryngol2002; 111:609–15.
